[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3989]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01303]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Noramco, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Noramco, Inc. applied to be registered as a manufacturer of 
certain basic classes of controlled substances. The DEA grants Noramco, 
Inc. registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: 
    By notice dated January 14, 2014, and published in the Federal 
Register on January 22, 2014, 79 FR 3627, Noramco, Inc., 500 Swedes 
Landing Road, Wilmington, Delaware 19801-4417, applied to be registered 
as a manufacturer of certain basic classes of controlled substances. No 
comments or objections were submitted to this notice. The Drug 
Enforcement Administration (DEA) has considered the factors in 21 
U.S.C. 823(a) and determined that the registration of Noramco, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Codeine-N-oxide (9053).....................  I
I=<gr-thn-eq>01<gr-thn-eq>>Dihydromorphine   I
 (9145).
Morphine-N-oxide (9307)....................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Phenylacetone (8501).......................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium extracts (9610)......................  II
Opium fluid extract (9620).................  II
Opium tincture (9630)......................  II
Opium, powdered (9639).....................  II
Opium, granulated (9640)...................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.

    Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01303 Filed 1-23-15; 8:45 am]
BILLING CODE P